Marshall Wace, LLP Sanara Med Tech Inc. Transaction History
Marshall Wace, LLP
- $81.7 Billion
- Q2 2025
A detailed history of Marshall Wace, LLP transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 71,511 shares of SMTI stock, worth $2.14 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,511
Previous 29,274
144.28%
Holding current value
$2.14 Million
Previous $903,000
124.81%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SMTI
# of Institutions
51Shares Held
1.07MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY197KShares$5.88 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA176KShares$5.25 Million0.0% of portfolio
-
Stonebridge Wealth Management, LLC Oak Brook, IL120KShares$3.57 Million3.2% of portfolio
-
Geode Capital Management, LLC Boston, MA77.7KShares$2.32 Million0.0% of portfolio
-
State Street Corp Boston, MA65.3KShares$1.95 Million0.0% of portfolio
About Sanara MedTech Inc.
- Ticker SMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 8,303,730
- Market Cap $248M
- Description
- Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...